Transforming Science into Medicine

아이디언스, AACR서 항암신약 후보 '베나다파립'연구 결과 발표
아이디언스 항암제 후보물질 IDX-1197 美FDA IND 통과
Idience is a science-driven biopharmaceutical company that changes oncology patients’ quality of life.

PIPELINE

Learn about our key pipeline of PARP inhibitor

LEADERSHIP TEAM

Meet the leadership team at Idience

CLINICAL PROGRAMS

Explore our clinical trials of PARP inhibitor

CAREERS

Join our team if you share our values, our dedication to patients and our passion for science